These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 5710084

  • 41. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV, Rudoĭ NM.
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract] [Full Text] [Related]

  • 42. [Basic and clinical study of 2-propyl isonicotinic thioamide (1321 Th)].
    Hokama S, Naruto H, Sugiura H, Matsumiya T, Fukuhara Y.
    Saishin Igaku; 1967 Sep 10; 22(9):2073-80. PubMed ID: 6082217
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Use of prothionamide in the treatment of pulmonary tuberculosis].
    Voitova DI, Zaitseva TI, Leont'eva GP, Milinder NM, Charikova LP.
    Probl Tuberk; 1971 Sep 10; 49(7):24-7. PubMed ID: 5162994
    [No Abstract] [Full Text] [Related]

  • 47. [Clinical effectiveness of ethionamide in chronic forms of pulmonary tuberculosis in middle-aged and elderly persons].
    Kurochkin SIa.
    Vrach Delo; 1971 Jun 10; (6):60-1. PubMed ID: 5093596
    [No Abstract] [Full Text] [Related]

  • 48. [Psychiatric and neurological symptoms caused by cycloserine poisoning].
    Nakamura K.
    Seishin Shinkeigaku Zasshi; 1968 Jun 10; 70(6):503-21. PubMed ID: 5749977
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Case of SIADH caused by ethionamide in a patient with pulmonary tuberculosis].
    Nakashita T, Motojima S.
    Kekkaku; 2006 Dec 10; 81(12):731-5. PubMed ID: 17240918
    [Abstract] [Full Text] [Related]

  • 51. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K, Hayashida M, Ishihara M, Ijichi F, Obata Y.
    Iryo; 1966 Mar 10; 20(3):257-63. PubMed ID: 5964832
    [No Abstract] [Full Text] [Related]

  • 52. [Therapeutic results in lung diseases caused by atypical mycobacteria].
    Fischer P, Schilling W.
    Z Erkr Atmungsorgane; 1984 Mar 10; 162(1):26-9. PubMed ID: 6202070
    [Abstract] [Full Text] [Related]

  • 53. [Effect of ethionamide on carbohydrate metabolism].
    Szelezyński K, Kalinowska L.
    Pol Tyg Lek; 1967 Dec 25; 22(52):2001-3. PubMed ID: 4869260
    [No Abstract] [Full Text] [Related]

  • 54. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND.
    Probl Tuberk Bolezn Legk; 2005 Dec 25; (12):37-9. PubMed ID: 16496762
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Concentration of ethionamide in the blood of patients with pulmonary tuberculosis].
    Bialik IB.
    Probl Tuberk; 1965 Dec 25; 43(9):71-6. PubMed ID: 5870634
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.